Epiceram Skin Barrier

Skin barrier Epiceram

health practitioners The EpiCeram Control Release Skin Barrier Emulsion is a proprietary skin barrier skin patch emulsion designed for the management of neurodermatitis. The EpiCeram contains 3 vital lipids - Ceramide, konjugated linoleic acids (CLA) and Cholesterin in a 3:1:1 physiological balance. EpiCeram is singularly designed to improve skin barrier functionality and is also free of steroids, perfumes, comedones, 1 paraaben and propane glycols.

The EpiCeram Skin Barrier Emulsion is used for the treatment of dehydrated skin and for the treatment and alleviation of burns and pruritus associated with various kinds of skin diseases, neurodermatitis, irritant skin irritation and radiative skin irritation. With EpiCeram, you can help reduce the strain on your skin that is arid and greasy by preserving a damp skin and skin surrounding that is conducive to the recovery of the skin.

The EpiCeram feeds the skin surrounding area to support the recovery processes in neurodermatitis sufferers. Wiping the cream onto the skin activates this two-stage application system. When EpiCeram is administered, a thin coat is applied to the affected skin twice daily (or as needed) and massaged into the skin delicately.

In case of skin fractures, the affected area should be dressed with a bandage of your own choosing after the procedure. The EpiCeram Skin Barrier Emulsion is an EpiCeram product for the prevention and prevention of skin barrier anomalies in skin inflammation. It is used in the prevention and prevention of skin inflammation. EpiCeram thus differentiates itself from other drugs such as correticosteroids and topically immunomodulating drugs by targeting the outside-in pattern of neurodermatitis pathophysiology.

While EpiCeram may be used in adult and pediatric settings, there are no limitations on the ages for which EpiCeram controlled release skin barrier emulsion may be used. Yes, EpiCeram can be applied to the face and skin wrinkles. EpiCeram is not subject to any limitations in terms of either site or use. EpiCeram showed asymptomatic alleviation in some subjects in conjunction with other available treatments such as correticosteroids and topically immunomodulating agents in a prospective, uncontrolled trial performed in subjects with minor to moderately severe ADS.

The researchers randomised 121 paediatric subjects with moderately to severely diagnosed acute respiratory distress to obtain EpiCeram or fluoresticasone proponate 0.05% creme in a randomised, five-centre, prospective, five-centre, blind trial. EpiCeram Certified Release Skin Barrier Emulsion reduces the seriousness of the underlying condition, reduces itching and improves sleeping patterns both 14 and 28 day after commencement of use.

Whereas fluid-sasone treatment showed a faster increase in these parameter after 14 day, both EpiCeram Controlled Release Skin Barrier Emulsion and fluid-sasone poor showed similar increases in recovery from stress, itching and sleeping patterns. However, EpiCeram is not indicated for individuals with known sensitivity to any of the ingredients of the formula.

The EpiCeram Controlled Release Skin Barrier Emulsion contains no solar protection and should always be used in combination with solar protection in areas subject to the outdoors. To be used in case of radiated skin dermatitis and/or in connection with radiotherapy after radiotherapy. Not to be used within 4 h before radiotherapy. Use twice a day or as directed by the radiotherapist.

In case the situation does not get better within 10 to 14 workingdays, seek medical advice. After EpiCeram use, a transient prickle may appear (10-15 minutes). The EpiCeram controlled release skin barrier emulsion is available in a 90g tubing and a 225g bubble free vacuum tub.

Mehr zum Thema